Q3 Earnings Forecast for Transcat Issued By Northland Capmk

Transcat, Inc. (NASDAQ:TRNS) – Analysts at Northland Capmk dropped their Q3 2025 EPS estimates for shares of Transcat in a report issued on Monday, December 16th. Northland Capmk analyst E. Jackson now anticipates that the scientific and technical instruments company will post earnings of $0.33 per share for the quarter, down from their previous estimate of $0.41. The consensus estimate for Transcat’s current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.51 EPS and FY2025 earnings at $1.68 EPS.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million during the quarter, compared to analyst estimates of $70.30 million. During the same period in the prior year, the firm posted $0.41 EPS. Transcat’s revenue was up 8.0% compared to the same quarter last year.

Other equities research analysts also recently issued research reports about the company. Northland Securities cut their price objective on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday, October 30th. Oppenheimer reiterated an “outperform” rating and issued a $130.00 price target (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research report on Tuesday, October 29th. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 target price on shares of Transcat in a report on Tuesday, October 29th. Finally, Craig Hallum raised their target price on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $130.25.

Transcat Stock Down 5.0 %

TRNS stock opened at $103.99 on Wednesday. The company has a market cap of $956.60 million, a price-to-earnings ratio of 52.52 and a beta of 0.70. Transcat has a twelve month low of $94.29 and a twelve month high of $147.12. The business has a 50 day moving average price of $110.56 and a two-hundred day moving average price of $118.95.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Virtu Financial LLC grew its position in Transcat by 127.0% during the third quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company’s stock worth $499,000 after buying an additional 2,314 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Transcat by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock worth $26,269,000 after purchasing an additional 11,106 shares in the last quarter. Barclays PLC increased its position in shares of Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock worth $1,826,000 after purchasing an additional 12,061 shares during the period. State Street Corp raised its stake in Transcat by 8.1% in the third quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock valued at $25,027,000 after purchasing an additional 15,514 shares in the last quarter. Finally, Needham Investment Management LLC lifted its position in Transcat by 43.6% during the third quarter. Needham Investment Management LLC now owns 39,500 shares of the scientific and technical instruments company’s stock worth $4,770,000 after purchasing an additional 12,000 shares during the period. 98.34% of the stock is owned by institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.